Joshua J Mooney1, Haley Hedlin2, Paul Mohabir3, Jay Bhattacharya4, Gundeep S Dhillon3. 1. Department of Medicine, Division of Pulmonary and Critical Care, Stanford University, Stanford, California, USA. Electronic address: jjmooney@stanford.edu. 2. Department of Medicine, Quantitative Sciences Unit, Stanford University, Stanford, California, USA. 3. Department of Medicine, Division of Pulmonary and Critical Care, Stanford University, Stanford, California, USA. 4. Department of Medicine, Center for Primary Care and Outcomes Research, Stanford University, Stanford, California, USA.
Abstract
BACKGROUND: The United States lung transplant registry data demonstrate differences in adult waitlist mortality by race/ethnicity. It is unknown whether these differences persist after risk adjustment or occur secondary to disparities in disease severity at the time of listing. METHODS: Adult lung transplant waitlist candidates between May 4, 2005 and March 5, 2015 were identified and compared by non-Hispanic white (NHW), non-Hispanic black (NHB), Hispanic and Asian race/ethnicity. A competing risk proportional hazards model was used to assess the association of race/ethnicity with the unadjusted and adjusted risk of waitlist death or removal for too sick, transplant, or removal for other reason. Disease illness severity at transplant listing was compared by race/ethnicity. RESULTS: There were 20,684 lung transplant candidates identified (82% NHW, 9% NHB, 6% Hispanic, 2% Asian and 1% other). Non-white candidates had higher unadjusted waitlist mortality, which was fully mitigated by adjusting for other risk factors (NHB: hazard ratio [HR] 1.05, 95% confidence interval [CI] 0.93 to 1.18; Hispanic: HR 1.02, 95% CI 0.99 to 1.18; Asian: HR 0.90, 95% CI 0.70 to 1.16). Adjusted waitlist access to transplant was lower in non-white candidates (NHB: HR 0.88, 95% CI 0.83 to 0.94; Hispanic: HR 0.87, 95% CI 0.81 to 0.94; Asian: HR 0.83, 95% CI 0.73 to 0.96). NHW candidates with obstructive lung disease and pulmonary fibrosis were older with less illness severity at listing than non-white candidates. CONCLUSIONS: Within the current lung allocation system, there is no difference in risk-adjusted waitlist mortality by race/ethnicity, but non-white waitlist candidates have lower risk-adjusted access to lung transplant. Non-white candidates are generally younger with greater disease-specific illness severity at the time of lung transplant listing.
BACKGROUND: The United States lung transplant registry data demonstrate differences in adult waitlist mortality by race/ethnicity. It is unknown whether these differences persist after risk adjustment or occur secondary to disparities in disease severity at the time of listing. METHODS: Adult lung transplant waitlist candidates between May 4, 2005 and March 5, 2015 were identified and compared by non-Hispanic white (NHW), non-Hispanic black (NHB), Hispanic and Asian race/ethnicity. A competing risk proportional hazards model was used to assess the association of race/ethnicity with the unadjusted and adjusted risk of waitlist death or removal for too sick, transplant, or removal for other reason. Disease illness severity at transplant listing was compared by race/ethnicity. RESULTS: There were 20,684 lung transplant candidates identified (82% NHW, 9% NHB, 6% Hispanic, 2% Asian and 1% other). Non-white candidates had higher unadjusted waitlist mortality, which was fully mitigated by adjusting for other risk factors (NHB: hazard ratio [HR] 1.05, 95% confidence interval [CI] 0.93 to 1.18; Hispanic: HR 1.02, 95% CI 0.99 to 1.18; Asian: HR 0.90, 95% CI 0.70 to 1.16). Adjusted waitlist access to transplant was lower in non-white candidates (NHB: HR 0.88, 95% CI 0.83 to 0.94; Hispanic: HR 0.87, 95% CI 0.81 to 0.94; Asian: HR 0.83, 95% CI 0.73 to 0.96). NHW candidates with obstructive lung disease and pulmonary fibrosis were older with less illness severity at listing than non-white candidates. CONCLUSIONS: Within the current lung allocation system, there is no difference in risk-adjusted waitlist mortality by race/ethnicity, but non-white waitlist candidates have lower risk-adjusted access to lung transplant. Non-white candidates are generally younger with greater disease-specific illness severity at the time of lung transplant listing.
Authors: D J Lederer; S M Arcasoy; R G Barr; J S Wilt; E Bagiella; F D'Ovidio; J R Sonett; S M Kawut Journal: Am J Transplant Date: 2006-07-26 Impact factor: 8.086
Authors: M Valapour; M A Skeans; B M Heubner; J M Smith; M I Hertz; L B Edwards; W S Cherikh; E R Callahan; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2015-01 Impact factor: 8.086
Authors: M Valapour; M A Skeans; J M Smith; L B Edwards; W S Cherikh; E R Callahan; A K Israni; J J Snyder; B L Kasiske Journal: Am J Transplant Date: 2016-01 Impact factor: 8.086
Authors: M Valapour; K Paulson; J M Smith; M I Hertz; M A Skeans; B M Heubner; L B Edwards; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2013-01 Impact factor: 8.086
Authors: Keith M Wille; Kathy F Harrington; Joao A deAndrade; Sonia Vishin; Robert A Oster; Richard A Kaslow Journal: J Heart Lung Transplant Date: 2013-04-09 Impact factor: 10.247
Authors: David J Lederer; Emma K T Benn; R Graham Barr; Jessie S Wilt; Genevieve Reilly; Joshua R Sonett; Selim M Arcasoy; Steven M Kawut Journal: Am J Respir Crit Care Med Date: 2007-11-15 Impact factor: 21.405
Authors: Christian A Merlo; Eric S Weiss; Jonathan B Orens; Marvin C Borja; Marie Diener-West; John V Conte; Ashish S Shah Journal: J Heart Lung Transplant Date: 2009-08 Impact factor: 10.247
Authors: M Valapour; M A Skeans; B M Heubner; J M Smith; M A Schnitzler; M I Hertz; L B Edwards; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2014-01 Impact factor: 8.086
Authors: Aparna C Swaminathan; Anne S Hellkamp; Megan L Neely; Shaun Bender; Luca Paoletti; Eric S White; Scott M Palmer; Timothy P M Whelan; Daniel F Dilling Journal: Ann Am Thorac Soc Date: 2022-06